Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-30 · accession 0001735276-25-000075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-03 | 2025-05-30+ | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $305.00 | -50.9K | 55.1K | -48% | -$15.54M |
| DM | 2025-06-03 | 2025-05-30+ | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $118.56 | +50.9K | 61.0K | +505% | +$6.04M |
| DM | 2025-06-03 | 2025-05-30+ | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | -50.9K | 839 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | S | D | 19,297 | $306.00 | 48,948 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-02 | M | A | 7,217 | $118.05 | 68,245 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-30 | S | D | 6,171 | $306.00 | 48,948 | D | — | — | |
| 4 | Common | Common Stock | 2025-06-02 | M | A | 12,080 | $119.13 | 61,028 | D | — | — | |
| 5 | Common | Common Stock | 2025-05-30 | S | D | 25,469 | $304.00 | 55,119 | D | — | — | |
| 6 | Common | Common Stock | 2025-05-30 | M | A | 19,559 | $118.05 | 80,588 | D | — | — | |
| 7 | Common | Common Stock | 2025-05-30 | M | A | 12,081 | $119.13 | 61,029 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2025-05-30 | M | D | 19,559 | $0.00 | 8,064 | D | $118.05 · — to 2030-02-25 | 19,559 Common Stock | (F3) This stock option was fully vested and exercisable as of February 26, 2024. |
| 9 | Derivative | Stock Option (right to buy) | 2025-06-02 | M | D | 7,217 | $0.00 | 847 | D | $118.05 · — to 2030-02-25 | 7,217 Common Stock | (F3) This stock option was fully vested and exercisable as of February 26, 2024. |
| 10 | Derivative | Stock Option (right to buy) | 2025-05-30 | M | D | 12,081 | $0.00 | 12,919 | D | $119.13 · — to 2028-02-28 | 12,081 Common Stock | (F4) This stock option was fully vested and exercisable as of December 1, 2021. |
| 11 | Derivative | Stock Option (right to buy) | 2025-06-02 | M | D | 12,080 | $0.00 | 839 | D | $119.13 · — to 2028-02-28 | 12,080 Common Stock | (F4) This stock option was fully vested and exercisable as of December 1, 2021. |